文献速递眼底病与葡萄膜炎

全反式视黄醛参与视网膜缺血再灌注诱导的血管通透性增加

All-trans-Retinaldehyde Contributes to Retinal Vascular Permeability in Ischemia Reperfusion.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2020-01-01

本研究在小鼠缺血再灌注(IR)模型中验证全反式视黄醛(atRAL)对视网膜血管通透性的贡献。通过Lrat-/-、暗适应或emixustat抑制视觉循环均使IR后48小时血管通透性降低约一半;atRAL可直接增加牛视网膜内皮细胞通透性并伴LDH释放,emixustat可阻断上述效应。

要点

  • 抑制视觉循环可减轻IR诱导的视网膜血管通透性。
  • atRAL直接作用于视网膜内皮细胞增加通透性并致细胞死亡。
  • emixustat可阻断atRAL对内皮细胞的通透性与毒性效应。

核心结论

  • 外视网膜释放的atRAL可直接作用于血管内皮细胞,改变屏障特性并诱导细胞死亡,从而参与IR诱导的视网膜血管通透性增加。

研究设计与样本

  • 小鼠经短暂眼内压升高后自然复流诱导视网膜缺血再灌注(IR)。
  • 在Lrat-/-小鼠中消除视觉循环,或通过暗适应、RPE65抑制剂及atRAL清除剂emixustat降低视觉循环。
  • 用FITC-BSA蓄积评估血管通透性,用DNA片段化定量IR后细胞死亡,并用原代牛视网膜内皮细胞(BREC)培养检测atRAL对内皮通透性和细胞死亡的直接效应。

主要发现

  • Lrat-/-、暗适应或emixustat抑制视觉循环均使IR后48小时血管通透性降低约一半。
  • atRAL增加BREC通透性,并伴随乳酸脱氢酶(LDH)释放(细胞死亡的指标)。
  • emixustat可阻断atRAL引起的BREC通透性增加和毒性。

关键数值与推荐

  • IR后48小时,Lrat-/-、暗适应或emixustat各使IR诱导的血管通透性降低约一半。

临床怎么用

  • 对伴外视网膜损伤和视网膜血管通透性的致盲眼病,atRAL通路及emixustat可能具有干预价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Extracellular accumulation of all-trans-retinaldehyde (atRAL), a highly reactive visual cycle intermediate, is toxic to cells of the outer retina and contributes to retinal and macular degenerations. However, the contribution of atRAL to retinal capillary function has not been studied. We hypothesized that atRAL released from the outer retina can contribute to retinal vascular permeability. We, therefore, tested the contribution of atRAL to retinal ischemia-reperfusion (IR)-induced vascular permeability. METHODS: IR was induced in mice by transient increase in intraocular pressure followed by natural reperfusion. The visual cycle was ablated in the Lrat-/- mice, reduced by dark adaptation or the use of the RPE65 inhibitor and atRAL scavenger emixustat. Accumulation of FITC-BSA was used to assess vascular permeability and DNA fragmentation quantified cell death after IR. Primary bovine retinal endothelial cell (BREC) culture was used to measure the direct effects of atRAL on endothelial permeability and cell death. RESULTS: Inhibition of the visual cycle by Lrat-/-, dark adaptation, or with emixustat, all reduced approximately half of IR induced vascular permeability at 48 hours. An increase in BREC permeability with atRAL coincided with lactate dehydrogenase (LDH) release, a measure of cell death. Both permeability and toxicity were blocked by emixustat. CONCLUSIONS: Outer retinal pathology may contribute to vascular permeability by release of atRAL, which can act directly on vascular endothelial cells to alter barrier properties and induce cell death. These studies may have implications for a variety of blinding eye diseases that include outer retinal damage and retinal vascular permeability.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Dreffs A, Lin CM, Liu X, et al. All-trans-Retinaldehyde Contributes to Retinal Vascular Permeability in Ischemia Reperfusion. Invest Ophthalmol Vis Sci. 2020. PMID: 32492112. doi:10.1167/iovs.61.6.8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。